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Previewsdirect toxic effects on synapses leading to
hippocampal dysfunction (Spires-Jones
and Hyman, 2014) (Figure 1). Recently
introduced methods for amyloid and tau
imaging in humans could provide insight
into the interaction between AD pathology
andBBBdisruption (Spires-Jones andHy-
man, 2014).
Owing to the cross-sectional design of
the study, the evolution in space and
time of the BBB alterations could not be
assessed in individual subjects. Although
Montagne et al. focused on cognitively
normal or mildly affected subjects, it
would be of instructive to examine the
spatiotemporal evolution of the BBB
alterations in MCI patients who go on to
develop frank AD. Recent data indicate
thatADpathology and theassociated syn-
aptic dysfunction spread throughout the
brain according to a stereotyped pattern,
largely reflecting neuronal connectivity
(Spires-Jones and Hyman, 2014). It would
be informative to determine if the BBB
alteration follows a similar progression
and, if so, whether it precedes or follows
the spread of amyloid and tau.
Another question concerns the role
of BBB disruption in white matter patho-
logy. Subcortical white matter lesions,
assumed to be on ischemic bases, are
common in older subjects and are animportant correlate of cognitive decline
in aging, MCI, and AD (Iadecola, 2013).
Although less pronounced than in the
hippocampus, Montagne et al. observed
a trend for increased permeability in the
white matter, especially in MCI, raising
the possibility that BBB leakage and
not ischemia is an early determinant of
white matter damage. Using their high-
resolution imaging method, it would be
feasible for the first time to determine
if BBB leakage precedes white matter
damage, which is still unsettled in the
literature (Iadecola, 2013). Irrespective of
the many questions still outstanding,
Montagne et al. provide new evidence
for a pivotal role of neurovascular
dysfunction in the pathobiology of cog-
nitive impairment in humans and open
up new and exciting research directions
with great diagnostic and therapeutic
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The subthalamic nucleus-globus pallidus network is a potential source of oscillations in Parkinson’s disease,
but the mechanism is unknown. In this issue of Neuron, Chu et al. (2015) present a cortically driven form of
heterosynaptic plasticity that could promote oscillatory activity after dopamine depletion.Neuronal oscillations can synchronize
activity within networks and across brain
regions (Buzsa´ki and Draguhn, 2004).Although they are a healthy form of
communication in many brain areas,
their dysregulation is being increasinglyobserved in a number of diseases.
Abnormal, excessive oscillatory activity
in Parkinson’s disease (PD), for example,, January 21, 2015 ª2015 Elsevier Inc. 233
Figure 1. Induction and Strengthening of GPe-STN Synapses by Cortically Driven hLTP
Left: Cortical (M1) activation of NMDA channels causes influx of calcium and activation of CaMKII that in-
duces two pathways: (1) synthesis and release of nitric oxide (NO), which activates a guanylate cyclase
(GC)-protein kinase G (PKG) pathway, and (2) insertion of GABAAR in deficient or silent synapses. Right:
Following stimulation, M1-STN synapses are strengthened by the insertion of AMPARs; GPe-STN synap-
ses are strengthened by an increase in postsynaptic GABAARs as well as an increase in presynaptic
release.
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Previewsdisrupts information transfer through the
cortico-basal ganglia circuit and impairs
normal selection or suppression of ac-
tions (Brown, 2007). PD is characterized
by the loss of dopamine in the basal
ganglia (BG) circuit that leads to devas-
tating motor dysfunction. Symptom pro-
gression has been linked to the appear-
ance of highly synchronized oscillatory
activity across cortico-basal ganglia re-
gions, particularly in the beta frequency
range (15–30 Hz) where the origin
and mechanism of action is unknown
(Brown 2007). Moreover, the current
treatments—dopamine replacement and
high-frequency deep brain stimulation—
target BG nuclei and often disrupt or
resolve abnormal beta oscillations, but
pathological activity patterns quickly re-
turn if treatments are interrupted.
The reciprocally connected subthalamic
nucleus (STN) and external segment of the
globus pallidus (GPe) form a central pace-
maker in the BG that has been implicated
in the onset, progression, and mainte-
nance of harmful oscillatory activity (Bevan
et al., 2002). In healthy individuals, STN-
GPe activity is desynchronized and uncor-
related, and its relationship to voluntary
movement is characterized by complex
spatiotemporal firing (Wichmann and De-
Long, 1996). The STN receives monosyn-
aptic cortical excitation, known as the hy-
perdirect pathway, which has been linked
to a rapid, immediate stop signal (Schmidt
et al., 2013). TheSTNalso receives indirect
cortical information through the GPe,
known as the indirect pathway, which is
responsible for the suppression or cancel-
lation of motor plans (Sano et al., 2013).234 Neuron 85, January 21, 2015 ª2015 ElseNeurons in the STN must integrate the
GABAergic input from theGPeand theglu-
tamatergic input from the cortex to appro-
priately stop or pause behaviors. There-
fore, the balance between cortical
excitation and pallidal inhibition are critical
for normal function, andperturbationsmay
underlie disease conditions.
In idiopathic and experimental PD, the
activity of STN-GPe network becomes
highly synchronized and rhythmic with
the emergence of beta-band frequency
activity (Bevan et al., 2002). The synaptic
mechanisms driving this change in
patterning are unknown, but the STN-
GPe network is well positioned to pro-
duce and propagate harmful oscillations.
Computational modeling paired with
experimental observations have shown
that extensive GPe collaterals, strong
but selective reciprocity of the STN-GPe
connections, and intrinsic autonomous
properties provide the necessary tools to
create a strong oscillator (Holgado et al.,
2010; Plenz and Kital, 1999). In this issue
of Neuron, Chu et al. discover that
high levels of cortical activity onto STN
neurons can induce heterosynaptic long-
term potentiation (hLTP) of GPe synap-
ses. Strengthening of GPe inputs to the
STN after dopamine depletion has been
shown previously (Fan et al., 2012), but
the important conceptual advance of the
present study is that the potentiation of
GPe synapses is mechanistically linked
to that of cortical synapses. The authors
hypothesize that under normal condi-
tions, hLTP serves an adaptive, homeo-
static role to maintain a healthy balance
between the hyperdirect and indirectvier Inc.pathway in the STN. However, after dopa-
mine depletion, pathologically elevated
cortical input to the STN triggers exces-
sive induction of hLTP at GPe synapses,
which becomes maladaptive to circuit
function and contributes to or even exac-
erbates pathological oscillations.
Several mechanisms of heterosynap-
tic plasticity have been described at
GABAergic synapses (Castillo et al.,
2011). One mechanism in particular,
NMDA-dependent release of nitric oxide
(NO) to strengthen nearby inhibitory
synapses (Nugent et al., 2007), was of
particular interest because STN neurons
contain the necessary synthase (nitric
oxide synthase [NOS]) while GPe neurons
contain the necessary transducers (gua-
nylate cyclase [GC] and protein kinase
G [PKG]). To study the mechanisms
of heterosynaptic long-term potentiation
(hLTP) in slices, Chu et al. transfected
the motor cortex (M1) with a channelr-
hodopsin-containing virus and optically
stimulated terminals in the STN. GPe
inputs were activated using electrical
stimulation through an electrode placed
within the internal capsule. Using multi-
ple pharmacological manipulations, the
authors demonstrate that presynaptic,
NO-dependent plasticity is present at
GPe-STN synapses. However, upon
further experimentation, the authors
found that a presynaptic mechanism
was not the only mechanism of hLTP at
the synapse. In the presence of a NOS in-
hibitor, postsynaptic hLTP was rescued
by directly activating NMDA receptors.
Two approaches were used to uncover
the postsynaptic mechanism contributing
to hLTP. First, immunohistochemistry re-
vealed an increase in the density of the
GABAAR scaffolding protein, gephyrin,
as well as an increase in the density of
the g2 subunit of the GABAAR after hLTP
induction, consistent with the findings of
Fan et al. (2012), in dopamine-depleted
tissue. Second, uncaging of RuBi-GABA
produced larger inhibitory responses after
hLTP induction compared to baseline,
consistent with the increase in the num-
ber of GABAAR observed immunohisto-
chemically. These results show for the
first time that hLTP has both a presynaptic
(NO-GC-PKG signal cascade) and post-
synaptic (SNARE-dependent insertion of
GABAARs) mechanism at the same syn-
apse (Figure 1).
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PreviewsTo determine whether hLTP is present
in vivo, the authors used a viral strategy
to knock down expression of the GluN1
subunit, and hence NMDARs, in a portion
of STN neurons; if hLTP is normally
engaged in vivo, the strength of inhibitory
inputs should be decreased onto neu-
rons lacking NMDARs. Comparisons of
the frequency and amplitude of miniature
inhibitory postsynaptic currents (mIPSCs)
recorded from infected and uninfected
neurons showed that inhibitory inputs
were indeed weakened onto neurons
lacking NMDARs in both control and
dopamine-depleted slices. These results
confirmed that NMDAR activity can
modulate the strength of GPe-STN in-
puts under both control and dopamine-
depleted conditions.
If the strengthening of GPe-STN synap-
ses via hLTP acts in a homeostatic
manner, then it should help to preserve a
constant ratio between excitation and in-
hibition. This prediction was tested under
control conditions, where the authors
measured the ratio of excitatory and
inhibitory synaptic inputs both pre- and
post-induction of hLTP. In support of a
homeostatic function, the ratio of excita-
tion and inhibition remained constant.
The fact that hLTP is regulated by the de-
gree of activity of cortical inputs to the
STN suggests that the excessive cortical
patterning that occurs after dopamine
loss could drive hLTP at GPe-STN synap-
ses to maximal capacity. To test this idea,
the authors attempted to induce hLTP in
acute slices prepared from dopamine-
depleted mice, but found that it was
occluded. This occlusion experiment im-
plies that hLTP is maximally engaged at
all GPe-STN synapses after dopamine
depletion. However, the results of the viral
knockdown experiment showed that
hLTP was also present at some synapses
under control conditions, so there may
be other factors contributing to hLTPocclusion after dopamine depletion. One
possibility is that hLTP ceases to be
homeostatic under dopamine-depleted
conditions, but the ratio between excit-
atory and inhibitory inputs was not
examined in dopamine-depleted mice,
so this remains an open question.
How might hLTP contribute to patho-
logical oscillations in the Parkinsonian
brain? We know from in vivo studies of
PD patients and animal models that
cortical excitation becomes more syn-
chronous and out of phase to pallidal inhi-
bition (Goldberg et al., 2002; Mallet et al.,
2008). This may be the force necessary
to activate NMDA-dependent plasticity
and drive the strengthening of GPe-STN
synapses. This increase in GPe synaptic
strength could then further promote path-
ological activity by deinactivation of Nav
channels (Baufreton et al., 2005). There-
fore, inducing hLTP in the STN-GPe
network that contains an intrinsic propen-
sity for oscillations (STN excites GPe, GPe
inhibits STN) would not only be able to
mimic the beta-band oscillations but
also propagate them to multiple brain
regions.
Interestingly, a patient with PD must
experience profound dopamine loss
before the onset of motor dysfunction.
The hLTP mechanism presented here
fits well into how this may occur. An indi-
vidual will experience a gradual loss of
dopamine, which results in changes in
firing rate and pattern of GPe and cortical
inputs and therefore engages hLTP. The
STN may be able to balance the changing
landscape of basal ganglia firing and
pattern for a period of time but eventually
is unable to overcome the loss of an
important neuromodulator and other
anatomical and physiological changes
in connected brain regions. There then
comes a point where the synaptic mecha-
nism switches from adaptive to maladap-
tive. Dopamine replacement therapy canNeuron 85restore some functionality to the circuit,
but if synaptic mechanisms such as
hLTP are not reversed, circuit dysfunction
will persist until solutions are found to
restore synaptic connections to healthy
states.REFERENCES
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